Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

Seeking Alpha / 1 Views

Study is expected to deliver final device data and documentation needed for planned FDA IND submission
Study is expected to deliver final device data and documentation needed for planned FDA IND submission

Comments